Population-based analysis of treatment modalities and survival for clinically localized small-cell carcinoma of the prostate

Prostate Cancer and Prostatic Diseases

Volumn 17, Issue 3, 2014, Pages 286-291

  Weiner, A B ^a   Patel, S G ^a   Richards, K A ^a   Szmulewitz, R Z ^a   Eggener, S E ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL EVALUATION; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; SMALL CELL CARCINOMA; TREATMENT RESPONSE; CAUSE OF DEATH; ETHNOLOGY; FACTUAL DATABASE; HEALTH SURVEY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; HUMANS; MALE; MIDDLE AGED; MORTALITY; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 84906303183     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2014.26     Document Type: Article

References (25)

1. Tetu B, Ro JY, Ayala AG, Johnson DE, Logothetis CJ, Ordonez NG. Small cell carcinoma of the prostate. Part I. A clinicopathologic study of cases. Cancer 1987; 59: 1803-1809.
2. Ro JY, Tetu B, Ayala AG, Ordonez NG. Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases. Cancer 1987; 59: 977-982.
3. Amato RJ, Logothetis CJ, Hallinan R, Ro JY, Sella A, Dexeus FH. Chemotherapy for small cell carcinoma of prostatic origin. J Urol 1992; 147(3 Pt 2): 935-937.
4. Nadal R, Schweizer M, Kryvenko ON, Epstein JI, Eisenberger MA. Small cell carcinoma of the prostate. Nat Rev Urol 2014; 11: 213-219.
5. Spiess PE, Pettaway CA, Vakar-Lopez F, Kassouf W, Wang X, Busby JE et al. Treatment outcomes of small cell carcinoma of the prostate: a single-center study. Cancer 2007; 110: 1729-1737.
6. Oesterling JE, Hauzeur CG, Farrow GM. Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. J Urol 1992; 147(Pt 2): 804-807.
7. Wang J, Wang FW. Impact of age on clinical presentation, treatment, and cancerspecific survival of patients with small-cell carcinoma of the prostate. Clin Interv Aging 2013; 8: 871-877.
8. Deorah S, Rao MB, Raman R, Gaitonde K, Donovan JF. Survival of patients with small cell carcinoma of the prostate during 1973-2003: a population-based study. BJU Int 2012; 109: 824-830.
9. Winchester DP, Stewart AK, Bura C, Jones RS. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol 2004; 85: 1-3.
10. Berglund A, Garmo H, Tishelman C, Holmberg L, Stattin P, Lambe M. Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden. J Urol 2011; 185: 833-839.
11. Akakura K, Suzuki H, Ichikawa T, Fujimoto H, Maeda O, Usami M et al. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Jpn J Clin Oncol 2006; 36: 789-793.
12. Boorjian SA, Karnes RJ, Viterbo R, Rangel LJ, Bergstralh EJ, Horwitz EM et al. Longterm survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer 2011; 117: 2883-2891.
13. American Joint Committee on Cancer, (Chicago, IL), Collection System User Documentation and Coding Instructions, version 02.03.02.
14. Epstein JI, Allsbrook Jr. WC, Amin MB, Egevad LL, Committee IG. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 1228-1242.
15. Anker CJ, Dechet C, Isaac JC, Akerley W, Shrieve DC. Small-cell carcinoma of the prostate. J Clin Oncol 2008; 26: 1168-1171.
16. Hindson DA, Knight LL, Ocker JM. Small-cell carcinoma of prostate. Transient complete remission with chemotherapy. Urology 1985; 26: 182-184.
17. Papandreou CN, Daliani DD, Thall PF, Tu SM, Wang X, Reyes A et al. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 2002; 20: 3072-3080.
18. Sule-Suso J, Brunt AM. Small cell carcinoma of the prostate. Br J Radiol 1992; 65: 726-728.
19. Helpap B, Kollermann J. Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis. Virchows Arch 1999; 434: 385-391.
20. Sella A, Konichezky M, Flex D, Sulkes A, Baniel J. Low PSA metastatic androgenindependent prostate cancer. Eur Urol 2000; 38: 250-254.
21. Lynch SP, Shen Y, Kamat A, Grossman HB, Shah JB, Millikan RE et al. Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol 2013; 64: 307-313.
22. Moore SR, Reinberg Y, Zhang G. Small cell carcinoma of prostate: effectiveness of hormonal versus chemotherapy. Urology 1992; 39: 411-416.
23. Bolton DM, Chiu ST, Clarke S, Angus D. Primary small cell carcinoma of the prostate: unusual modes of presentation. Aust N Z J Surg 1994; 64: 91-94.
24. Palmgren JS, Karavadia SS, Wakefield MR. Unusual and underappreciated: small cell carcinoma of the prostate. Semin Oncol 2007; 34: 22-29.
25. Aggarwal R, Zhang T, Small EJ, Armstrong AJ. Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomes. J Natl Compr Cancer Netw 2014; 12: 719-726.